Table 5 Outcome measurements
| Outcome | When they will be evaluated | |||
|---|---|---|---|---|
| Baseline | 12 weeks | 26 weeks | 52 weeks | |
| Primary: | ||||
| NDI | x | x | x | x |
| Arm pain (NRS) | x | x | x | x |
| Secondary: | ||||
| Neck pain (NRS) | x | x | x | x |
| Patient expectations | x | |||
| Perceived recovery | x | x | x | |
| Success rate | x | x | x | |
| EuroQol (EQ-5D and EQ-VAS) | x | x | x | x |
| FABQ | x | x | x | x |
| HSCL-10 | x | x | x | x |
| Medicine consumption | x | x | x | x |
| Sickness absence | x | x | x | x |
| Dysphagia | x | x | x | x |
| Frequency of surgical complications | x | x | x | |
| Frequency of reoperations | x | x | x | |
| Cross overs in the nonsurgical group | x | x | x | |
| Patient demographics | x | |||
| Neurological status, incl. Grip strength | x | x | x | x |